-+ 0.00%
-+ 0.00%
-+ 0.00%

Immutep Ltd. publishes phase II study results on neoadjuvant eftilagimod alpha, pembrolizumab, and radiotherapy in resectable soft tissue sarcoma

Reuters·10/19/2025 14:53:03

Please log in to view news